Each year, CPNP provides 45 of your required 100 hours of BCPP Recertification credit. Don't miss out on 2021's newest releases and order today! Although course materials and examinations are not available until release dates, you can pre-register and order online today!
 |
Psychiatric Pharmacotherapy Review Course
The Psychiatric Pharmacotherapy Review Course (Released: 1/6/21; Closes: 9/30/21) is an excellent way to develop and maintain contemporary knowledge and skills at the psychiatric pharmacy specialty level.
|
|
|
|
 |
Literature Analysis
The Literature Analysis (Released: 2/26/21; Closes: 11/30/21) product is an excellent way to maintain up-to-date knowledge on current research in the field of psychiatric pharmacy. Participants study and analyze up to 10 current pieces of literature on various topic areas.
|
|
|
|
 |
Clinical Application Series
Through the Clinical Application Series (Released: 4/20/21; Closes: 10/19/21), you will learn from thought leaders in the field as they delve into the topics of Antipsychotic Adverse Effects Comparison, Harm Reduction Strategies in Opioid Use Disorder, Role of Newer Antidepressants in Social Anxiety Disorder (SAD), Pharmacologic Management of Insomnia with Sleep Apnea and Management of Acute Repetitive Seizures.
|
 |
From Theory to Practice Case Series
From Theory to Practice Case Series (Releases: 9/28/21; Closes 3/28/22) provides the opportunity to study a complex psychiatric case comorbid with a medical diagnosis and associated complex medication regimen. A patient is followed over three encounters with each one consisting of a case study, pre-recorded webinar, and self-assessment questions. This edition is focused on personality disorders.
|
 |
Psychopharmacology Pearls
Psychopharmacology Pearls (Releases: 11/9/21; Closes 5/9/22) consists of four clinical review articles focused on single disorders, or on one or more distinct aspects of a single psychiatric, neurologic, or substance use disorder. These case-based articles will offer therapeutic advice based on both evidence and longstanding clinical experience. Topics include long-term consequences of antidepressants, mood stabilizers, and antipsychotics in pediatric patients, managing acute agitation and aggression in the world of drug shortages, pearls for monitoring and treating antipsychotic induced metabolic syndrome, and treatment of stimulant use disorder.
|
